News

STORM Therapeutics Strengthens Board with Appointment of Professor Paul Workman, President and CEO of The Institute of Cancer Research

STORM Therapeutics, the drug discovery company focused on the discovery of small molecule therapies modulating RNA epigenetics, today announced the appointment of Professor Paul Workman to its Board.

Read the press release

RNA Epigenetics in Human Disease

A STORM Therapeutics conference | 17-20 September 2019

Find out more

Speakers

  • Reuven Agami
  • Shankar Balasubramanian
  • Thomas Carell
  • Robert Copeland
  • Tom Cech
  • Michaela Frye
  • Francois Fuks
  • Richard Gregory
  • Chuan He
  • Stacy Horner
  • Samie Jaffrey
  • Narry Kim
  • Jeannie Lee
  • Michal Minczuk
  • Gidi Rechavi
  • Tom Suzuki